STOCK TITAN

Armistice Capital and Steven Boyd report 4.99% stake in Soligenix (SNGX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

SOLIGENIX, INC. ownership disclosure: Armistice Capital, LLC and Steven Boyd report beneficial ownership of 4.99% equal to 529,731 shares of common stock as of 12/31/2025.

The filing states Armistice Capital is investment manager of the Master Fund, which is the direct holder, and that Armistice and Mr. Boyd exercise shared voting and dispositive power over the reported 529,731 shares. The Master Fund disclaims beneficial ownership due to the Investment Management Agreement.

Positive

  • None.

Negative

  • None.

Insights

Armistice reports a sub-5% stake and shared control over 529,731 shares.

Armistice Capital, as investment manager to the Master Fund, and Steven Boyd, as managing member, are reported to hold shared voting and dispositive power over 4.99% (529,731 shares) as of 12/31/2025. The Master Fund is identified as the direct holder.

The filing preserves the Master Fund's disclaimer of beneficial ownership under the Investment Management Agreement; timing of any future transactions is not disclosed in the excerpt.

Schedule 13G/A shows passive ownership disclosure and joint filing mechanics.

The statement is filed as a joint Schedule 13G/A with a joint filing statement and signatures dated 02/17/2026. It classifies the position as ownership of 5 percent or less of a class and includes details of voting and dispositive power (shared: 529,731).

Disclosure notes who may receive dividends or proceeds (the Master Fund). No change-in-control or purchaser intentions are asserted in the provided text.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Armistice Capital, LLC
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd - Managing Member
Date:02/17/2026
Steven Boyd
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd
Date:02/17/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: February 17, 2026 Armistice Capital, LLC By: /s/ Steven Boyd Steven Boyd - Managing Member Steven Boyd By: /s/ Steven Boyd

FAQ

What stake does Armistice Capital report in SNGX?

Armistice Capital reports beneficial ownership of 529,731 shares, representing 4.99% of Soligenix common stock as of 12/31/2025. The Master Fund is listed as the direct holder while Armistice exercises voting and investment power.

Who is listed as the direct holder of the SNGX shares?

The filing identifies Armistice Capital Master Fund Ltd. as the direct holder of the reported shares. Armistice Capital is the Master Fund's investment manager and exercises voting and dispositive power over those shares.

Does Steven Boyd personally own the reported SNGX shares?

Steven Boyd is reported as managing member of Armistice Capital and is attributed shared voting and dispositive power over 529,731 shares (4.99%). The Master Fund disclaims beneficial ownership due to its agreement with Armistice.

When was the Schedule 13G/A signed for SNGX?

The joint filing statement is signed by Steven Boyd with signature dates shown as 02/17/2026. The ownership percentage is reported as of 12/31/2025 in the excerpt.

Does the filing state any intent to sell or acquire more SNGX shares?

The excerpt classifies the position under "Ownership of 5 percent or less of a class" and does not state any plans to buy or sell additional securities. No transaction intentions are disclosed in the provided text.
Soligenix Inc

NASDAQ:SNGX

SNGX Rankings

SNGX Latest News

SNGX Latest SEC Filings

SNGX Stock Data

10.99M
9.65M
Biotechnology
Pharmaceutical Preparations
Link
United States
PRINCETON